Medicines co /de (MDCO)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Net loss

-73,994

-60,055

-59,865

-42,474

-55,634

-54,197

29,149

-178,260

-30,175

-397,268

-102,670

-122,858

-86,271

182,421

-92,464

-206,072

-105,141

-46,539

5,006

-5,380

-16,789

-5,174

-5,005

1,086

7,746

18,034

-11,606

20,581

9,264

13,754

7,571

19,582

72,614

11,440

24,241

58,572

21,205

15,426

9,432

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

453

498

501

1,218

534

715

728

4,300

5,947

3,697

8,030

8,525

7,931

7,243

7,343

10,657

9,251

7,368

7,561

8,358

9,014

9,088

7,938

12,270

7,153

7,086

5,729

1,869

1,715

1,997

1,689

1,717

1,523

1,442

1,549

1,039

1,360

1,421

2,304

Amortization of net premiums and discounts on available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-6

-72

-131

-221

-234

-181

-98

0

-518

-715

-788

-828

-836

-887

-709

Amortization of long term debt financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

339

326

320

307

300

289

283

272

268

58

0

-

-

-

-

-

-

-

-

Amortization of Debt Discount (Premium)

9,530

9,072

9,161

7,396

6,995

6,786

6,745

6,543

6,503

6,849

6,973

6,790

6,622

6,470

6,300

6,144

6,096

5,920

5,516

4,031

2,673

2,621

2,595

2,544

2,519

2,470

2,445

2,398

2,389

519

0

-

-

-

-

-

-

-

-

Unrealized foreign currency transaction losses, net

239

665

-706

-54

238

641

-768

-904

-753

-171

-352

816

-139

-309

573

-403

430

-5

151

-54

359

415

113

-19

-75

-121

72

75

297

-209

410

34

-304

251

-543

621

-189

260

525

Stock compensation expense

4,340

5,747

4,446

4,826

4,171

4,619

4,454

7,442

7,878

9,557

6,643

6,446

7,990

9,611

6,940

6,632

7,690

8,665

7,618

9,575

8,413

8,951

7,372

7,168

5,450

5,849

4,611

3,849

3,837

4,180

3,115

2,641

2,902

3,214

2,260

1,481

1,775

2,338

2,742

Deferred tax benefit

-

-

-

-

-

-

-

-

-

-

-

1,638

-38

-756

-867

-9,899

-25,081

-17,879

-433

-6,897

1,864

-2,201

1,669

-6,882

-759

2,799

-5,430

22,143

4,100

4,133

0

15,139

-66,296

-2,301

212

-44,302

-147

531

326

Excess tax benefit from share-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

229

-282

-266

42

-3

1,670

1,704

289

2,034

3,648

506

813

-133

372

9,393

0

0

0

-

-

-

-

Gain on sale of business

0

0

0

0

0

0

168,955

0

0

0

0

0

0

288,301

1,004

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of assets

0

0

500

21,556

7,026

0

0

-

-

-

-

-

-

-

-

0

-13

0

-530

-16

-7

-5

-7

-7

-6

-7

-19

-23

-18

-68

40

11

-310

0

0

-287

0

0

-6

Gain (Loss) on Investments

-

-

-300

-

-

-

-30,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on remeasurement of equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-144

22,741

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reserve for excess or obsolete inventory

0

0

0

2

2

16

-410

15,656

-350

2,147

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in contingent purchase price

0

0

0

0

0

4

-262

-6,999

-7,672

-12,628

8,512

10,408

12,237

2,708

-1,372

5,855

747

12,259

1,417

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss in equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-144

-527

-1,184

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment to contingent purchase price

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,264

-

-5,480

5,284

364

3,662

-1,065

-573

-564

7,773

-788

-766

-1,263

545

-787

-755

-723

Changes in operating assets and liabilities:
Accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

0

-74

-75

-198

-66

114

127

-201

-69

-452

188

-572

364

-335

321

14

Accounts receivable

0

0

0

1,236

-5,576

-4,825

4,206

5,296

-7,768

-7,108

400

-6,019

-20,151

5,606

-9,580

12,697

-12,844

-46,921

-56,032

36,786

-462

15,647

2,768

-2,789

13,077

-143

4,872

2,268

17,577

-1,666

-7,059

2,075

6,025

17,699

2,287

12,413

12,955

-8,323

-418

Inventory, net

0

-1,001

138

3

56

-1,045

-1,213

-4,535

-4,581

1,815

790

1,576

3,858

7,872

2,347

11,535

3,139

8,638

46,006

6,424

-10,965

34

-1,120

-4,968

4,616

2,488

7,994

13,963

15,104

-2,683

4,768

14,821

1,404

-3,420

6,989

-4,357

1,027

3,511

-882

Prepaid expenses and other assets

-1,057

696

-1,727

-4,114

1,138

-1,135

-5,552

5,352

-1,291

-688

-3,907

1,338

-4,603

3,331

-635

-2,092

6,102

2,490

-1,214

407

2,741

97

314

-2,244

1,466

-8,252

8,991

-2,850

384

363

587

4,161

-1,286

-6,375

10,263

-2,581

1,204

-2,131

-1,523

Accounts payable

3,041

-7,442

11,098

-6,833

1,937

-267

-4,351

-324

-4,828

-1,098

-10,972

9,867

-7,945

11,239

-20,559

18,475

52

3,977

-6,142

11,586

996

127

-19,575

-7,289

26,155

-5,037

-15,148

18,941

-818

-9,877

10,657

-4,008

-6,724

4,186

4,343

-4,110

4,702

1,060

-1,487

Accrued expenses

-5,560

8,803

-14,313

8,384

-25,521

-23,322

-9,931

36,771

-6,775

22,925

-21,395

11,877

-10,733

-7,196

-31,181

-17,846

14,631

7,944

-44,230

27,585

-31,837

20,570

7,740

3,783

20,741

8,885

-2,217

-27,205

27,051

-127

-39,879

39,344

23,240

6,419

2,605

11,745

-7,783

4,781

-9,479

Other current liabilities

41

0

0

-120

-136

-134

-4,047

-2,050

-6,747

-4,666

-294

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on contingent purchase price

0

0

0

0

2

38

19

44

40,062

94

12,343

1,045

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-2,311

-5,443

1,993

-16,775

27,560

-1,466

-933

7,655

298

1,391

-4,087

2,260

1,623

1,095

-1,124

521

-237

1,389

12

-493

789

-250

79

75

-114

-253

-324

Other liabilities

-1,262

-2,992

-2,912

-33

83

-40

4,262

-4,470

-603

2,569

-5,155

-5,293

-4,524

-825

-804

6,735

-268

-205

-5,713

6,672

1,639

-2,334

-2,583

1,154

48

48

85

-402

48

46

43

43

42

43

43

-60

44

44

34

Net cash used in operating activities

-60,711

-48,775

-49,823

-39,027

-57,427

-56,020

-109,321

-63,514

-129,422

-55,750

-119,602

-62,324

-48,656

-93,949

-118,380

-112,504

-3,455

-40,977

-41,029

20,070

2,701

49,632

-5,089

41,834

57,169

40,382

-47,965

25,653

14,645

21,095

-15,047

35,766

24,319

17,331

18,959

18,842

8,003

33,352

7,270

Cash flows from investing activities:
Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

250

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

28,132

37,222

-252

0

0

33,835

27,410

34,975

34,573

31,282

Proceeds from sale of assets

0

0

500

2,772

9,900

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities and sales of available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

8,100

15,500

27,056

13,845

0

3,000

22,036

24,357

37,745

24,261

40,350

28,500

29,040

26,214

24,886

Purchases of fixed assets

0

0

0

0

0

0

7

0

77

3,115

1,333

-

-

-

0

134

933

856

632

1,209

649

2,038

3,393

5,886

4,529

2,307

852

310

207

488

0

390

520

54

305

189

32

96

23

Payments for intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

15,000

7,000

90,617

0

15,000

0

0

-

-

-

-

0

0

0

36,678

7,000

0

0

0

-

-

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,000

0

0

875

2,000

500

0

0

-

-

-

-

-

-

-

-

Acquisition of business, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

28,397

0

63

58,808

63

140,000

100,879

1

301,699

0

0

0

0

-

-

-

-

-

-

-

-

Proceeds from Divestiture of Businesses

0

0

0

0

0

0

166,383

0

0

0

0

0

0

263,807

174,068

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment to goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

263

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

3,648

-1

13

26

-48

4

-17

-7

-10

8

-83

-9

5

-2

-5

0

-1,140

28

-2,036

94

-1,149

-1

7

7

-1,285

-7

7

Net cash provided by investing activities

0

0

500

2,772

9,900

0

166,376

42,191

89,267

-134,675

-1,333

2,404

-4,739

253,979

174,055

-160

-15,885

11,913

-119,379

-1,202

-18,702

-61,479

-3,373

-143,877

-87,313

3,194

-276,365

11,535

433

-25,648

-49,828

9,625

38,374

24,208

6,203

894

-4,682

-8,448

-6,163

Cash flows from financing activities:
Proceeds from issuances of common stock, net

5,463

5,439

672

13

3,682

3,230

8,683

7,913

4,849

11,165

24,694

6,372

10,493

11,807

5,104

5,480

68,933

8,810

11,975

3,661

4,176

924

8,582

15,043

9,608

19,826

29,735

1,329

11,533

6,193

3,880

2,753

1,052

731

2,189

597

254

1,676

834

Payments on contingent purchase price

0

0

0

0

0

340

171

404

554

842

8,723

1,483

1,399

3,749

2,773

27,543

3,275

125,783

1,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Milestone payments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of convertible senior notes

0

0

9,500

163,000

0

0

0

-

-

-

-

-

-

-

-

0

0

0

400,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs

0

0

280

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

12,769

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of shares of non-controlling interest

-

-

-

-

-

-

-

0

0

0

167

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from share-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

229

-282

-266

42

-3

1,670

1,704

289

2,034

3,648

506

813

-133

372

9,393

0

0

0

-

-

-

-

Net cash provided by financing activities

5,463

167,022

9,892

157,549

3,682

2,890

8,512

7,507

4,292

-44,674

15,804

4,889

9,094

54,262

2,331

-22,063

65,711

-116,744

397,924

-6,558

4,218

921

10,252

16,747

199,497

21,860

33,383

1,835

12,346

202,488

4,252

12,146

1,052

731

2,189

597

254

1,676

834

Effect of exchange rate changes on cash

-240

1,112

856

-392

0

-412

-962

-1,066

190

802

16

114

461

-292

-983

-908

-306

1,478

-1,184

2,192

-248

820

-141

-337

116

-936

-108

34

625

-1,122

768

-190

-1,318

564

-941

862

-102

326

624

Increase (decrease) in cash, cash equivalents and restricted cash

-55,488

119,359

-38,575

120,902

-43,845

-53,542

64,605

-14,882

-35,673

-234,297

-105,115

-54,917

-43,840

214,000

57,023

-135,635

46,065

-144,330

236,332

14,502

-12,031

-10,106

1,649

-85,633

169,469

64,500

-291,055

39,057

28,049

196,813

-59,855

57,347

62,427

42,834

26,410

21,195

3,473

26,906

2,565

Supplemental disclosure of cash flow information:
Interest paid

14,006

0

10,534

0

10,535

0

10,534

0

10,573

377

11,611

378

5,000

1,891

5,000

1,891

5,055

1,891

0

-

-

-

-

2,483

0

1,891

0

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

3

24

25

28

16

45

53

118

20

1,180

6,637

1,400

-300

1,400

554

136

1,005

14

67

20

6,163

600

1,470

29

85

115